Long-term survival of advanced lung adenocarcinoma by maintenance chemotherapy followed by EGFR-TKI: A case report.
Qing Yun LiJi Min ShenYing Ni LinWei DuJian Ping ZhouPublished in: Medicine (2021)
The patient benefited from maintenance chemotherapy and epidermal growth factor receptor-tyrosine kinase inhibitor treatment and achieved long-term survival.